Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Walgreens Boots Alliance, Inc. (WBA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
10-K
| Annual Report for the period ended August 31, 2023 |
| 10/12/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10% stake in Walgreens Boots Alliance Inc. |
| 08/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Delayed Draw Term Loan Credit Agreement, by and among Walgreens Boots Alliance, Inc., the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent",
"Three-Year Revolving Credit Agreement, by and among Walgreens Boots Alliance, Inc., the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent and Swing Line Lender" |
|
| 08/07/2023 |
4
| Walgreens Boots Alliance, Inc. (10% Owner) has filed a Form 4 on AMERISOURCEBERGEN CORP|
Txns:
| Sold 1,320,858 shares
@ $189.271, valued at
$250M
Acquired 262,500 options to buy
@ $0
Acquired 525,000 options to buy
@ $0
Acquired 1,050,000 options to buy
@ $0
Acquired 1,312,500 options to buy
@ $0
Acquired 1,575,000 options to buy
@ $0
Acquired 2,625,000 options to buy
@ $0 |
|
| 08/07/2023 |
3
| Heckman Todd (Interim Global Controller) has filed a Form 3 on Walgreens Boots Alliance, Inc. |
| 08/07/2023 |
SC 13D/A
| Walgreens Boots Alliance, Inc. reports a 15.8% stake in AMERISOURCEBERGEN CORPORATION |
| 07/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
4
| DRISCOLL JOHN PATRICK (EVP, Pres. U.S. Healthcare) has filed a Form 4 on Walgreens Boots Alliance, Inc.|
Txns:
| Bought 5,172 shares
@ $28.4191, valued at
$147k
|
|
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
SC 13D/A
| Walgreens Boots Alliance, Inc. reports a 0% stake in Option Care Health, Inc. |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/15/2023 |
4
| Walgreens Boots Alliance, Inc. (10% Owner) has filed a Form 4 on AMERISOURCEBERGEN CORP|
Txns:
| Sold 292,792 shares
@ $170.77, valued at
$50M
Disposed of 918,000 options to buy
@ $0
Disposed of 1,836,000 options to buy
@ $0 |
|
| 05/15/2023 |
SC 13D/A
| Walgreens Boots Alliance, Inc. reports a 16.5% stake in AMERISOURCEBERGEN CORPORATION |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
4
| Kehoe James (EVP and Global CFO) has filed a Form 4 on Walgreens Boots Alliance, Inc.|
Txns:
| Paid exercise price by delivering 6,020 shares
@ $35.25, valued at
$212.2k
|
|
| 05/01/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
4
| BREWER ROSALIND G (CEO) has filed a Form 4 on Walgreens Boots Alliance, Inc.|
Txns:
| Bought 10,000 shares
@ $33.951, valued at
$339.5k
|
|
| 03/28/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/21/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/21/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"Consent of PricewaterhouseCoopers LLP, independent auditor of Summit Health-CityMD",
"Summit Health-CityMD Audited Consolidated Financial Statements as of December 31, 2021 and for the year ended December 31, 2021",
"Summit Health-CityMD Unaudited Condensed Consolidated Financial Statements as of and for the nine months ended September 30, 2022",
"Unaudited Pro Forma Condensed Combined Financial Information consisting of the Unaudited Pro Forma Condensed Combined Balance Sheet as of November 30, 2022, the Unaudited Pro Forma Condensed Combined Statement of Earnings for the year ended August 31, 2022 and the Unaudited Pro Forma Condensed Combined Statement of Earnings for the three months ended November 30, 2022" |
|
|
|
|